Author: Staff

Misonix CEO Michael A. McManus, Jr., has been selected as a top CEO at a micro-cap company for 2014 by ExecRank.

Anika Therapeutics appointed Glenn R. Larsen, PhD, as a new independent member of its board of directors.

OrthAlign announced that Gary D. Henley will join its board of directors as executive chairman.

Here are five tips to improve productivity during your work week, according to an Entrepreneur article: 

Paul Slosar, MD, an orthopedic spine surgeon, serves as president of San Francisco-based SpineCare Medical Group as well as the medical director of the Spine Care Institute of San Francisco, co-director of the San Francisco Spine Institute and director of…

Froedtert and the Medical College of Wisconsin Froedtert Hospital in Milwaukee became the next clinical site for InVivo Therapeutics' spinal cord injury treatment investigational device exemption clinical trial.

Orthopedic injuries are a hazard of the job for professional athletes. Yet, most athletes are able to undergo treatment — sometimes surgery — and then return to an elite level of play.

DJO Global reported net sales growth during the fourth quarter of 2014, as well as for the full year, but also posted a net loss.

The National Football League suspended helmet sensor use in a voluntary pilot program designed for researchers to collect data about how often, and hard, players are hit in the head, according to a New York Times report.

Vertex Pharmaceuticals recently acquired a spinal cord injury repair drug from BioAxome Bioseicneces, which could be the company's saving grace after the hepatitis C drug Vertex took a gamble on failed, according to an Xconomy report.